F/m Emerald Life Sciences Innovation ETF LFSC
45.75 USD +1.67 (+3.79%)
Nov 4, 2026, 1:43 PM EST
44.76 Day range 45.78
31.02 52-week range 48.78
- YTD
- +24.93%
- 1 year
- +43.91%
- Market cap
- 123.57M
- YTD return
- +24.93%
- 1-year return
- +43.91%
- Volume
- 3.45K
- Avg volume
- 3.75K
- Open
- 45.16
- Previous close
- 44.08
- Day's range
- 44.76 – 45.78
- 52-week range
- 31.02 – 48.78
1M +1.83 (+4.16%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 25.58
- 200-day average
- 25.58
Next earnings
Consensus EPS estimate 0.00.
News
Spyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis Drug 
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application 
FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer 
Travere Stock Slips After FDA Delays Review Of Key Kidney Drug 
This New ETF Doesn't Wait For Stability — It Profits From Disruption 
LFSC: A New Small-Cap Health Care ETF Prioritizing Innovation Before Profits
Your note
Sign in to keep a note on LFSC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Financial Investors Tr-Emerald Growth Fund | 92.29% | 2,000,000 | 47.48M | Oct 30, 2024 |